brightgreen.us (BGXX): Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization

Bright Green (BGXX) holds a rare federal cannabis cultivation license, positioning itself for dominance in the medical research sector. The firm's operations are constrained by strict DEA regulations and volatile electricity tariffs. The localization of all capacities within the US ensures shipment stability. The market trend for the EV/EBITDA multiple has fixed the indicator at , confirming the current business valuation.

BGXX Bright Green Corporation: Enterprise Value to EBITDA Ratio in the range 07/04/2022 - 11/14/2026

Comprehensive metric breakdowns and analytics for Bright Green Corporation (BGXX)

- current price and projected stock value:

Stock Price Bright Green Corp.|BGXX - Analyst Consensus Forecast

- stock exchange capitalization data:

Market Value Bright Green Corp.|BGXX - Value Adjusted for Debt and Cash

- book value of equity indicators:

Net Assets per Single Share Bright Green|BGXX - Company Net Assets|Market Capitalization to Book Value Ratio brightgreen.us|BGXX - Aggregate Company Assets

- debt and solvency information:

- business earnings and investment ratios data:

BGXX - Profit After Payment of Taxes|Future Profit Bright Green|BGXX - Company Value to Net Income|Forward P/E Multiple Bright Green Corp|BGXX - Price to Net Income Growth Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Bright Green Corp.|BGXX - Income before deduction of interest, taxes and amortization|Net earnings per share (EPS TTM) Bright Green|BGXX - Net earnings per one share for the last twelve months|Quarterly EPS earnings growth brightgreen.us|BGXX - Earnings per share growth rate in current year|Net earnings per share growth forecast for next year Bright Green

- sales and revenue data:

BGXX - Company Sales Volume|Projected Sales Volume Bright Green Corp|BGXX - Price-to-Revenue Ratio|Forward P/S Multiple Bright Green Corporation

Comprehensive company analysis:brightgreen.us BGXX

The EV/EBITDA multiple compares the total enterprise value of a business with its operating profit, excluding the impact of debt load and tax regimes. For Bright Green (BGXX), the EV/EBITDA multiple on the time chart reflects cost management efficiency amid a high dependence on external logistics providers and research centers. A decrease in this indicator signals either an undervalued asset or an increase in operational risks associated with outsourcing.

Main competitors

EV/EBITDA Multiple INDV (Indivior Corp)|EV/EBITDA Multiple collegiumpharma.com COLL|CRON - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Canopy Growth Corporation (CGC) - Enterprise Value to EBITDA Ratio|Canna Cabana (HITI) - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|Aurora Cannabis (ACB) - EV/EBITDA Multiple|ACHV (Achieve Life Sciences Inc) - EV/EBITDA Multiple|Skye Bioscience Inc. (SKYE) - Total Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Anebulo (ANEB)|Canndoc - Enterprise Value to Operating Income Before Depreciation|Nutriband - Enterprise Value to EBITDA Ratio|Total Company Value to Operating Income Before Depreciation Ratio nasuspharma.com (NSRX)|IGC - Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|MIRA - EV/EBITDA Multiple|FLGC: EV/EBITDA Multiple|IMC (IMCC) - EV/EBITDA Multiple|Enterprise Value to EBITDA Ratio ADIL|Company Value to EBITDA Artelo Biosciences, Inc. ARTL|EV/EBITDA Multiple ENSC|TTNP: Company Value to Operating Income Before Depreciation Ratio|Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization Greenlane Holdings Inc GNLN|EV/EBITDA Multiple InMed Pharmaceuticals Inc INM|Akanda Corp - EV/EBITDA Multiple|ENVB: Enterprise Value to Earnings Before Interest, Taxes, Depreciation and Amortization|HPCO: EV/EBITDA Multiple